• Users Online: 87
  • Print this page
  • Email this page
Year : 2020  |  Volume : 24  |  Issue : 1  |  Page : 52-53

Treatment of refractory dissecting cellulitis of the scalp with guselkumab: Case report

1 Department of Dermatology, University of Connecticut, Farmington, USA
2 Central Connecticut Dermatology, Cromwell, USA
3 Central Connecticut Dermatology, Cromwell; Department of Dermatology, Yale University, New Haven, CT, USA

Correspondence Address:
Ms. Sonal Muzumdar
University of Connecticut School of Medicine, 21 South Road, 2nd Floor, Farmington, CT06032
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jdds.jdds_50_19

Get Permissions

Dissecting cellulitis (DC) of the scalp is a chronic, clinically refractory inflammatory skin disorder. Herein is a presentation of a male with refractory DC with concurrent hidradenitis suppurativa, who had failed treatment with multiple topical and systemic therapies. After receiving guselkumab, 100 mg subcutaneously every 8 weeks, the patient exhibited marked improvement, with normalization of symptoms and signs.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded235    
    Comments [Add]    

Recommend this journal